CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.
May 13th 2024
The Food and Drug Administration will speed up its review of SNB-101 to treat patients with small cell lung cancer.
FDA Fast Tracks Investigational Drug for Potential Approval in Lung Cancer Subtype
October 4th 2022Treatment with an investigational drug elicited a median progression-free survival (time from treatment until disease progression or death) of 8.9 months among patients with a form of unresectable or metastatic squamous non-small cell lung cancer, according to trial findings.